Analysis of Treg markers revealed a more activated phenotype of intrahepatic Tregs compared to circulating Tregs, with tumor-infiltrating Tregs expressing higher levels of activation markers such as ICOS and GITR. This evidence concerns the gene TNFRSF18 and neoplasm.